Sleep Disturbances in Patients with Medical Conditions

Psychiatric Clinics of North America

Volumn 38, Issue 4, 2015, Pages 825-841

  Kamath, Jayesh ^a   Prpich, Galina ^a   Jillani, Sarah ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cognitive behavioral therapy; Comorbidities; Inflammation; Insomnia; Medical conditions; Sleep disturbances; Symptom cluster

Indexed keywords

CARDIOMETABOLIC RISK; COGNITIVE THERAPY; COMORBIDITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MANAGED CARE; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PATIENT EDUCATION; PERIODIC LIMB MOVEMENT DISORDER; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESTLESS LEGS SYNDROME; REVIEW; RISK FACTOR; SCREENING TEST; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP WAKING CYCLE; SYMPTOM ASSESSMENT; TREATMENT PLANNING; COMPLICATION; DISEASE MANAGEMENT; MULTIMODALITY CANCER THERAPY; NEOPLASM; SLEEP WAKE DISORDERS;

COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES; PAIN; RISK FACTORS; SLEEP WAKE DISORDERS;

EID: 84947445891     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2015.07.011     Document Type: Review

References (89)

1. Sleep disorders problems. In: National Sleep Foundation Web site. Available at:. Accessed May 1, 2015. http://sleepfoundation.org/sleep-disorders-problems.
2. Palesh O.G., Roscoe J.A., Mustian K.M., et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 2010, 28(2):292-298.
3. Dickerson S.S., Sabbah E.A., Ziegler P., et al. The experience of a diagnosis of advanced lung cancer: sleep is not a priority when living my life. Oncol Nurs Forum 2012, 39(5):492-499.
4. Fiorentino L., Rissling M., Liu L., et al. The symptom cluster of sleep, fatigue and depressive symptoms in breast cancer patients: severity of the problem and treatment options. Drug Discov Today Dis Models 2011, 8(4):167-173.
5. Barun B. Pathophysiological background and clinical characteristics of sleep disorders in multiple sclerosis. Clin Neurol Neurosurg 2013, 115(Suppl 1):S82-S85.
6. Fiorentino L., Ancoli-Israel S. Sleep dysfunction in patients with cancer. Curr Treat Options Neurol 2007, 9(5):337-346.
7. Le Grande M.R., Jackson A.C., Murphy B.M., et al. Relationship between sleep disturbance, depression and anxiety in the 12 months following a cardiac event. Psychol Health Med 2015, 11:1-8.
8. Bazil C.W. Epilepsy and sleep disturbance. Epilepsy Behav 2003, 4(Suppl 2):S39-S45.
9. Collop N. Sleep and sleep disorders in chronic obstructive pulmonary disease. Respiration 2010, 80(1):78-86.
10. Ali T., Choe J., Awab A., et al. Sleep, immunity and inflammation in gastrointestinal disorders. World J Gastroenterol 2013, 19(48):9231-9239.
11. Roizenblatt M., Rosa Neto N.S., Tufik S., et al. Pain-related diseases and sleep disorders. Braz J Med Biol Res 2012, 45(9):792-798.
12. Reynolds C.F., Redline S., DSM-V Sleep-Wake Disorders Workgroup and Advisors The DSM-V sleep-wake disorders nosology: an update and an invitation to the sleep community. J Clin Sleep Med 2010, 6(1):9-10.
13. Winokur A. The Relationship between sleep disturbances and psychiatric disorders: Introduction and Overview. Psychiatr Clin N Am 2015, in press.
14. Reynolds C.F., O'Hara R. DSM-5 sleep-wake disorders classification: overview for use in clinical practice. Am J Psychiatry 2013, 170(10):1099-1101.
15. Guzman-Marin R., Avidan A.Y. Sleep disorders in patients with cancer. J Community Support Oncol 2015, 13(4):148-155.
16. Howell D., Oliver T.K., Keller-Olaman S., et al. Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice. Ann Oncol 2014, 25(4):791-800.
17. Harsora P., Kessmann J. Nonpharmacologic management of chronic insomnia. Am Fam Physician 2009, 79(2):125-130.
18. Lobentanz I.S., Asenbaum S., Vass K., et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 2004, 110(1):6-13.
19. Attarian H.P., Brown K.M., Duntley S.P., et al. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol 2004, 61(4):525-528.
20. Merlino G., Fratticci L., Lenchig C., et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med 2009, 10(1):26-34.
21. Bamer A.M., Johnson K.L., Amtmann D., et al. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler 2008, 14(8):1127-1130.
22. Braley T.J., Chervin R.D., Segal B.M. Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography. Mult Scler Int 2012, 2012:673936.
23. Placidi F., Diomedi M., Scalise A., et al. Effect of anticonvulsants on nocturnal sleep in epilepsy. Neurology 2000, 54(5 Suppl 1):S25-S32.
24. Beran R.G., Plunkett M.J., Holland G.J. Interface of epilepsy and sleep disorders. Seizure 1999, 8(2):97-102.
25. Deak M.C., Kirsch D.B. Sleep-disordered breathing in neurologic conditions. Clin Chest Med 2014, 35(3):547-556.
26. Moldofsky H. Rheumatic manifestations of sleep disorders. Curr Opin Rheumatol 2010, 22(1):59-63.
27. Foo H., Mason P. Brainstem modulation of pain during sleep and waking. Sleep Med Rev 2003, 7(2):145-154.
28. Roehrs T., Hyde M., Blaisdell B., et al. Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006, 29(2):145-151.
29. Banack H.R., Holly C.D., Lowensteyn I., et al. The association between sleep disturbance, depressive symptoms, and health-related quality of life among cardiac rehabilitation participants. J Cardiopulm Rehabil Prev 2014, 34(3):188-194.
30. Berger A.M. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum 2009, 36(4):E165-E177.
31. Savard J., Morin C.M. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001, 19(3):895-908.
32. Bastien C.H., Vallières A., Morin C.M. Precipitating factors of insomnia. Behav Sleep Med 2004, 2(1):50-62.
33. Howell D., Oliver T.K., Keller-Olaman S., et al. A Pan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer. Support Care Cancer 2013, 21(10):2695-2706.
34. Bower J.E., Ganz P.A., Irwin M.R., et al. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?. J Clin Oncol 2011, 29(26):3517-3522.
35. Graci G. Pathogenesis and management of cancer-related insomnia. J Support Oncol 2005, 3(5):349-359.
36. Boonstra L., Harden K., Jarvis S., et al. Sleep disturbance in hospitalized recipients of stem cell transplantation. Clin J Oncol Nurs 2011, 15(3):271-276.
37. Dickerson S.S., Connors L.M., Fayad A., et al. Sleep-wake disturbances in cancer patients: narrative review of literature focusing on improving quality of life outcomes. Nat Sci Sleep 2014, 6:85-100.
38. Fleming L., Gillespie S., Espie C.A. The development and impact of insomnia on cancer survivors: a qualitative analysis. Psychooncology 2010, 19(9):991-996.
39. Cappuccio F.P., D'Elia L., Strazzullo P., et al. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010, 33(5):585-592.
40. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007, 21(2):153-160.
41. Besedovsky H.O., del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996, 17(1):64-102.
42. Frank M.G., Baratta M.V., Sprunger D.B., et al. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007, 21(1):47-59.
43. Godbout J.P., Chen J., Abraham J., et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 2005, 19(10):1329-1331.
44. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007, 21(1):9-19.
45. Miller A.H., Ancoli-Israel S., Bower J.E., et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 2008, 26(6):971-982.
46. Irwin M.R. Inflammation at the intersection of behavior and somatic symptoms. Psychiatr Clin North Am 2011, 34(3):605-620.
47. Surani S.R. Diabetes, sleep apnea, obesity and cardiovascular disease: why not address them together?. World J Diabetes 2014, 5(3):381-384.
48. Vernon M.K., Dugar A., Revicki D., et al. Measurement of non-restorative sleep in insomnia: a review of the literature. Sleep Med Rev 2010, 14(3):205-212.
49. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14(6):540-545.
50. Sleep disorders - for health professionals (PDQ). In: National Cancer Institute Website. 2014. Available at:. Accessed June 10, 2015. http://www.cancer.gov/about-cancer/treatment/side-effects/sleep-disorders-hp-pdq.
51. Schutte-Rodin S., Broch L., Buysse D., et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008, 4(5):487-504.
52. Morin C.M., Bootzin R.R., Buysse D.J., et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006, 29(11):1398-1414.
53. Epstein D.R., Dirksen S.R. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum 2007, 34(5):E51-E59.
54. Garland S.N., Johnson J.A., Savard J., et al. Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat 2014, 10:1113-1124.
55. Espie C.A. "Stepped care": a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009, 32(12):1549-1558.
56. Mustian K.M., Sprod L.K., Janelsins M., et al. Exercise recommendations for cancer-related fatigue, cognitive impairment, sleep problems, depression, pain, anxiety, and physical dysfunction: a review. Oncol Hematol Rev 2012, 8(2):81-88.
57. Payne J.K., Held J., Thorpe J., et al. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 2008, 35(4):635-642.
58. Carlson L.E., Garland S.N. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 2005, 12(4):278-285.
59. Mustian K.M., Sprod L.K., Janelsins M. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol 2013, 31(26):3233-3241.
60. Jacobs G.D., Pace-Schott E.F., Stickgold R., et al. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 2004, 164(17):1888-1896.
61. Morin C.M., Colecchi C., Stone J., et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999, 281(11):991-999.
62. Depner C.M., Stothard E.R., Wright K.P. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 2014, 14(7):507.
63. Jackson C.L., Redline S., Emmons K.M. Sleep as a potential fundamental contributor to disparities in cardiovascular health. Annu Rev Public Health 2015, 36:417-440.
64. Reutrakul S., Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci 2014, 1311:151-173.
65. McNicholas W.T., Verbraecken J., Marin J.M. Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev 2013, 22(129):365-375.
66. Mozaffarian D., Hao T., Rimm E.B., et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011, 364(25):2392-2404.
67. Spiegelhalder K., Fuchs L., Ladwig J., et al. Heart rate and heart rate variability in subjectively reported insomnia. J Sleep Res 2011, 20(1 Pt 2):137-145.
68. Macey P.M., Woo M.A., Kumar R., et al. Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients. PLoS One 2010, 5(4):e10211.
69. Genta-Pereira D.C., Pedrosa R.P., Lorenzi-Filho G., et al. Sleep disturbances and resistant hypertension: association or causality?. Curr Hypertens Rep 2014, 16(8):459.
70. Costanzo M.R., Khayat R., Ponikowski P., et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol 2015, 65(1):72-84.
71. Moser R.J., Rajagopal K.R. Obstructive sleep apnea in adults with tonsillar hypertrophy. Arch Intern Med 1987, 147(7):1265-1267.
72. Watanabe T., Isono S., Tanaka A., et al. Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep-disordered breathing. Am J Respir Crit Care Med 2002, 165(2):260-265.
73. Young T., Skatrud J., Peppard P.E. Risk factors for obstructive sleep apnea in adults. JAMA 2004, 291(16):2013-2016.
74. Patil S.P., Schneider H., Schwartz A.R., et al. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 2007, 132(1):325-337.
75. Dancey D.R., Hanly P.J., Soong C., et al. Gender differences in sleep apnea: the role of neck circumference. Chest 2003, 123(5):1544-1550.
76. Grandner M.A. Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?. Int Rev Psychiatry 2014, 26(2):155-176.
77. Böing S., Randerath W.J. Sleep disorders in asthma and chronic obstructive pulmonary disease (COPD). Ther Umsch 2014, 71(5):301-308.
78. Gilat H., Vinker S., Buda I., et al. Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study. Medicine (Baltimore) 2014, 93(9):e45.
79. Pack A.I., Black J.E., Schwartz J.R., et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001, 164(9):1675-1681.
80. Krakow B., Melendrez D., Lee S.A., et al. Refractory insomnia and sleep-disordered breathing: a pilot study. Sleep Breath 2004, 8(1):15-29.
81. Silber M.H., Becker P.M., Earley C., et al. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc 2013, 88(9):977-986.
82. Malhotra A., Orr J.E., Owens R.L. On the cutting edge of obstructive sleep apnoea: where next?. Lancet Respir Med 2015, 3(5):397-403.
83. Trenkwalder C., Högl B., Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009, 256(4):539-553.
84. Connor J.R., Wang X.S., Allen R.P., et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 2009, 132(Pt 9):2403-2412.
85. Connor J.R., Boyer P.J., Menzies S.L., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61(3):304-309.
86. Cervenka S., Pålhagen S.E., Comley R.A., et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006, 129(Pt 8):2017-2028.
87. Salas R.E., Rasquinha R., Gamaldo C.E. All the wrong moves: a clinical review of restless legs syndrome, periodic limb movements of sleep and wake, and periodic limb movement disorder. Clin Chest Med 2010, 31(2):383-395.
88. Gamaldo C.E., Benbrook A.R., Allen R.P., et al. Childhood and adult factors associated with restless legs syndrome (RLS) diagnosis. Sleep Med 2007, 8(7-8):716-722.
89. Mendelson W.B. Are periodic leg movements associated with clinical sleep disturbance?. Sleep 1996, 19(3):219-223.